News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Microbicides news

Show

From To
Microbicides
MTN begins first trial of new dapivirine ring with both anti-HIV drug and contraceptive

Researchers hoping for a single product to protect against both HIV and unintended pregnancy took an important step toward realizing their goal with the start of a trial of a vaginal ring containing the antiretroviral drug dapivirine and a hormonal contraceptive. A dapivirine-only ring that women use a month at a time was safe and helped prevent HIV in two large trials. The new ring adds levonorgestrel and could be used for three months.

Published
03 May 2017
From
Eurekalert Medicine & Health
Women
Bacterial vaginosis does not affect efficacy of oral PrEP in women

Research presented at the Conference on Retroviruses and Opportunistic Infections (CROI 2017) found that the efficacy of oral pre-exposure prophylaxis (PrEP) for women was not affected

Published
23 February 2017
By
Gus Cairns
Microbicides
Vaginal Ring Form of PrEP Does Not Reduce Contraceptive Effectiveness

The antiretroviral (ARV)-containing vaginal ring form of pre-exposure prophylaxis (PrEP) that reduced HIV risk in a major trial does not lower the effectiveness of hormonal birth control. This finding assuages concerns raised by previous research that the non-nucleoside reverse transcriptase inhibitor (NNRTI) class of ARVs has been associated with a lowered effectiveness of some hormonal contraceptives.

Published
16 February 2017
From
Poz
HIV prevention policy
New HIV prevention products will need marketing and effective health services to reach the people who need them

There is a naivety among many HIV prevention researchers and advocates about the steps needed to introduce and implement new HIV prevention technologies such as oral pre-exposure

Published
24 October 2016
By
Roger Pebody
Microbicides
New microbicide enema achieves high levels of drug in rectal tissues in monkeys

Rectal microbicides that protect against HIV transmission via anal sex are a bigger technical challenge than vaginal ones. The rectal lining is more delicate than the vaginal, so

Published
22 October 2016
By
Gus Cairns
Microbicides
Rings, films or inserts? Researchers need to develop prevention products that make sense in women’s lives

“We need to think outside of the box,” Sharon Hillier of the Microbicide Trials Network told the HIV Research for Prevention (HIVR4P 2016) conference in Chicago

Published
21 October 2016
By
Roger Pebody
The biology of HIV transmission
Vaginal and rectal bacteria may have a big influence on HIV transmission and microbicide efficacy

A number of presentations at the 2016 HIV Research for Prevention Conference (HIVR4P) in Chicago looked at the influence vaginal bacteria have on HIV susceptibility, and one

Published
20 October 2016
By
Gus Cairns
PrEP
London gay men anticipate some pros and cons of different PrEP methods – but optimal efficacy is key to acceptability

When presented with a range of possible HIV prevention technologies – a daily pill, pills before and after sex, injections, or a rectal gel – gay men

Published
09 September 2016
By
Roger Pebody
Microbicides
Vaginal ring for HIV prevention effective and acceptable

An updated adherence analysis from the ASPIRE study indicates that consistent users of a vaginal ring containing dapivirine experienced 65% fewer infections, the 21st International AIDS Conference (AIDS 2016) in

Published
02 September 2016
By
Roger Pebody
Microbicides
Vaginal bacteria increase HIV susceptibility and may reduce PrEP effectiveness

Overgrowth of a certain species of vaginal bacteria was associated with a 13-fold higher likelihood of acquiring HIV, while another species was found to lower tenofovir levels

Published
15 August 2016
By
Liz Highleyman
← Prev1...23456...26Next →

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.